Category
Metabolic & Weight Loss
GLP-1 agonist comparisons, drug interaction guides, and evidence-based peptide guides for fat loss and metabolic health.
4 articles
Setmelanotide: The Peptide for Genetic Obesity and How MC4R Works
Read article
GLP-1s in Type 1 Diabetes: The First Expert Recommendations
Read article
Ozempic, Wegovy, Rybelsus and the Wegovy Pill: One Molecule, Four Products
Read article
When 'Retatrutide' Isn't: What Independent Testing Has Found
Read article
GLP-1s and the Brain: Alcohol, Addiction and Dementia in 2026
Read article
GLP-1 Hair Shedding and 'Ozempic Face': What's the Drug and What's the Weight Loss
Read article
GLP-1s Before Surgery: The Aspiration-Risk Guidance, Explained
Read article
MOTS-c: From Exercise-Mimetic Science to the FDA's Compounding Committee
Read article
GLP-1 Pens and Vials Decoded: Clicks, Units and Dose Math for Every Device
Read article
Compounded, Branded or 'Research' Tirzepatide: Identity, Purity and Law Side by Side
Read article
Retatrutide vs CagriSema vs Tirzepatide: The Next-Generation Scorecard
Read article
Stopping a GLP-1: The Weight-Regain Data and What Actually Helps
Read article
Amylin: The Hormone Behind the Next Weight-Loss Wave (Cagrilintide, Petrelintide, Eloralintide, Amycretin)
Read article
GLP-1s and Birth Control: Why Tirzepatide Can Make the Pill Less Reliable
Read article
Muscle Loss on GLP-1s: What the Body-Composition Data Shows
Read article
CagriSema's FDA Decision: What It Is, What the Trials Showed, and What to Watch
Read article
GLP-1 Microdosing: What the First Real-World Data Shows, and What No Trial Has Tested
Read article
What Is 'GLP-3'? Decoding the Gray-Market Code Names for Retatrutide, Tirzepatide and Semaglutide
Read article
Semaglutide vs Tirzepatide: What the Head-to-Head Trials Show
Read article →
GLP-1 Drug Interactions: What the Labels Actually Say
Read article →
Peptides for Fat Loss: What the Trials Show
Read article →